07:00 , Sep 1, 2016 |  BC Innovations  |  Translation in Brief

Bacteria with a pulse

A UCSD-led team has programmed bacteria to deliver controlled pulses of therapeutic proteins in vivo, and is spinning out Gencirq LLC to commercialize the technology. In a study in Nature , the orally delivered bacteria...
07:00 , Oct 14, 2002 |  BioCentury  |  Strategy

Spendthrifty

One of the more important benefits of the 1999-2000 funding frenzy was that companies were given enough money to generate broad pipelines. Coming into 2001 flush with cash, CEOs were able to turn up the...
07:00 , May 26, 1998 |  BC Week In Review  |  Company News

Biocircuits diagnostics/imaging news

BIOC ceased operations after it was unsuccessful in securing financing or arranging a sale or merger of the company. The company will liquidate and/or sell its assets. BioCircuits Corp. (BIOC), Sunnyvale, Calif.   Business: Diagnostics/Imaging...
07:00 , May 18, 1998 |  BC Week In Review  |  Clinical News

Biocircuits regulatory update

BIOC filed a 510 (k) with the FDA for marketing clearance of the company's PSA assay to diagnose and monitor prostate cancer. The assay is designed for use with BIOC's IOS immunodiagnostic system. Biocircuits Corp....
07:00 , Apr 13, 1998 |  BC Week In Review  |  Clinical News

Biocircuits regulatory update

The FDA granted marketing approval for BIOC's Free T4 assay, which measures the free T4 hormone to diagnose thyroid disease. Partner Becton Dickinson and Co. (Franklin Lakes, N.J.) will market the test. Biocircuits Corp. (BIOC),...
08:00 , Mar 9, 1998 |  BC Week In Review  |  Clinical News

Biocircuits regulatory update

BIOC submitted a 510(k) with the FDA for marketing clearance of its Free T4 assay. The assay is designed for use with BIOC's point-of-care IOS immunodiagnostics system. Free T4 is a hormone that is measured...
08:00 , Jan 19, 1998 |  BC Week In Review  |  Clinical News

IOS immunoassay system: BIOC started clinical evaluation

Biocircuits Corp. (BIOC), Sunnyvale, Calif.   Product: IOS immunoassay system to measure prostate specific antigen (PSA)   Indication: Manage previously diagnosed prostate cancer   Status: BIOC started clinical evaluation for a prostate cancer cartridge for...
08:00 , Jan 12, 1998 |  BC Week In Review  |  Clinical News

IOS immunoassay system to measure free T4 hormone: BIOC began clinical evaluation

Biocircuits Corp. (BIOC), Sunnyvale, Calif.   Product: IOS immunoassay system to measure free T4 hormone   Indication: Diagnose thyroid disorders   Status: BIOC began clinical evaluation of a new cartridge for the IOS assay for...
08:00 , Dec 22, 1997 |  BC Week In Review  |  Clinical News

IOS system: Update

Biocircuits Corp. (BIOC), Sunnyvale, Calif.   Product: IOS system   Indication: Monitor digoxin   Status: BIOC began clinical evaluation of a new test cartridge for immunoassay of digoxin for use in its IOS system. The...
08:00 , Nov 3, 1997 |  BC Week In Review  |  Company News

Biocircuits, Becton Dickinson deal

The companies completed a licensing agreement under which Becton Dickinson's Microbiology Systems Division (Sparks, Md.) received exclusive worldwide marketing rights to BIOC's IOS point-of-care immunodiagnostic testing system (see BioCentury, July 7). Four tests are available...